Pfizer Requests Adjustment to Storage Temperatures From the FDA

Pfizer, maker of one of the two currently approved COVID-19 vaccinations, has asked the United States Food and Drug Administration (FDA) to adjust its vaccine’s required storage temperature from -112°F to -76°F to -13°F to -5°F. The new temperature range is provided by traditional pharmaceutical freezers and refrigerators, whereas the colder range requires a special subzero freezer. Pfizer asserts that the vaccine can be safely stored between -13°F and -5°F for up to 2 weeks. The pharmaceutical company has provided the FDA with additional data demonstrating the safety of such a move. If the FDA approves, the change would simplify the distribution process for the Pfizer vaccine. Click here to read more.